Half-year report · Q2
5199.TEDINET S100UO35
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥7.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥135m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥247m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥120m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥382m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥240m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥98m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥238m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥58m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥290m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥58m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥11.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.4bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.4bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.8bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥211m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥153m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥53m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥123m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥53m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥90m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥347m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥283m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.82 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.42 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥227m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥70m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥309m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥224m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥224m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥5m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.6bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥362m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥239m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥2m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥459m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥397m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥397m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥486m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 511
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 212538000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 18976000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Income before income taxes | Prior1YTDDuration | 238324000 | JPY |
| Income before income taxes | CurrentYTDDuration | 97565000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 155098000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 143662000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 7000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -6000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 1330000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 60011000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -5459000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -6037000 | JPY |
| Insurance income ope cf | Prior1YTDDuration | － | JPY |
| Insurance income ope cf | CurrentYTDDuration | -145000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 26917000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 27068000 | JPY |
| Commission for syndicate loan ope cf | Prior1YTDDuration | 4632000 | JPY |
| Commission for syndicate loan ope cf | CurrentYTDDuration | 3750000 | JPY |
| Amortization of bond issuance cost ope cf | Prior1YTDDuration | 1013000 | JPY |
| Amortization of bond issuance cost ope cf | CurrentYTDDuration | 1013000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -80914000 | JPY |
| Loss on retirement of property plant and equipment ope cf | Prior1YTDDuration | 232000 | JPY |
| Loss on retirement of property plant and equipment ope cf | CurrentYTDDuration | 33000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -22744000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -48622000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -159564000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 103683000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 98945000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -116003000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -37437000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -45057000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | -1158000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | -2567000 | JPY |
| Increase decrease in other provision ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in other provision ope cf | CurrentYTDDuration | 4465000 | JPY |
| Other net ope cf | Prior1YTDDuration | -35188000 | JPY |
| Other net ope cf | CurrentYTDDuration | 59578000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 264949000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 201478000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 5459000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 6037000 | JPY |
| Proceeds from insurance income ope cf | Prior1YTDDuration | － | JPY |
| Proceeds from insurance income ope cf | CurrentYTDDuration | 145000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -27045000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -26722000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -90582000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | 19714000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |